• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 0.16% Nasdaq Down 0.13%

    Exelixis, Inc. (EXEL)

    -NasdaqGS
    3.34 Down 0.10(2.91%) 4:00PM EDT
    |After Hours : 3.34 0.00 (0.00%) 4:32PM EDT
    Add to Portfolio
    Prev Close:3.44
    Open:3.45
    Bid:3.33 x 500
    Ask:3.40 x 4000
    1y Target Est:2.50
    Beta:1.71
    Earnings Date:Jul 29 - Aug 3 (Est.)
    Day's Range:3.32 - 3.48
    52wk Range:1.26 - 4.55
    Volume:2,105,164
    Avg Vol (3m):3,388,940
    Market Cap:654.73M
    P/E (ttm):N/A
    EPS (ttm):-1.17
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for EXEL

    Comparison

    Symbol% ChgMkt Cap
    EXELDown 2.91%654.73M
    AZNDown 0.06%84.69B
    GSKUp 0.20%106.84B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):22.79
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :-0.79
    Quarterly EPS Est (Jun-15) :-0.21
    Mean Recommendation*:2.6
    PEG Ratio (5 yr expected):0.18

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Exelixis, Inc., a biopharmaceutical company, develops and sells small molecule therapies for the treatment of cancer in the United States. The company offers COMETRIQ, an inhibitor of multiple receptor tyrosine kinases for the treatment of patient... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback